{
  "DOI": "10.1016/j.ajhg.2023.09.001",
  "ISSN": [
    "0002-9297"
  ],
  "URL": "http://dx.doi.org/10.1016/j.ajhg.2023.09.001",
  "alternative-id": [
    "S0002929723003142"
  ],
  "assertion": [
    {
      "label": "This article is maintained by",
      "name": "publisher",
      "value": "Elsevier"
    },
    {
      "label": "Article Title",
      "name": "articletitle",
      "value": "Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank"
    },
    {
      "label": "Journal Title",
      "name": "journaltitle",
      "value": "The American Journal of Human Genetics"
    },
    {
      "label": "CrossRef DOI link to publisher maintained version",
      "name": "articlelink",
      "value": "https://doi.org/10.1016/j.ajhg.2023.09.001"
    },
    {
      "label": "Content Type",
      "name": "content_type",
      "value": "article"
    },
    {
      "label": "Copyright",
      "name": "copyright",
      "value": "© 2023 American Society of Human Genetics."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Li",
      "given": "Binglan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Sangkuhl",
      "given": "Katrin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Whaley",
      "given": "Ryan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Woon",
      "given": "Mark",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Keat",
      "given": "Karl",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Whirl-Carrillo",
      "given": "Michelle",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ritchie",
      "given": "Marylyn D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Klein",
      "given": "Teri E.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "The American Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": true,
    "domain": [
      "ajhg.org",
      "elsevier.com",
      "sciencedirect.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        9,
        26
      ]
    ],
    "date-time": "2023-09-26T14:29:27Z",
    "timestamp": 1695738567000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T07:46:23Z",
    "timestamp": 1712303183000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        19
      ]
    ],
    "date-time": "2024-04-19T19:28:46Z",
    "timestamp": 1713554926336
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "print",
      "value": "0002-9297"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2023,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2023,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            10,
            1
          ]
        ],
        "date-time": "2023-10-01T00:00:00Z",
        "timestamp": 1696118400000
      }
    },
    {
      "URL": "http://www.elsevier.com/open-access/userlicense/1.0/",
      "content-version": "vor",
      "delay-in-days": 187,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            5
          ]
        ],
        "date-time": "2024-04-05T00:00:00Z",
        "timestamp": 1712275200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929723003142?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0002929723003142?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "page": "1628-1647",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2023,
        10
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        10
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "DOI": "10.1002/cpt.2350",
      "article-title": "An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine",
      "author": "Whirl-Carrillo",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib1",
      "volume": "110",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.1654",
      "article-title": "PharmVar and the Landscape of Pharmacogenetic Resources",
      "author": "Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib2",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-021-00920-y",
      "article-title": "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)",
      "author": "Matic",
      "doi-asserted-by": "crossref",
      "first-page": "1105",
      "journal-title": "Eur. J. Hum. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib3",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1002/cpt.1651",
      "article-title": "The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later",
      "author": "Relling",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib4",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010814-124835",
      "article-title": "Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers",
      "author": "Dunnenberger",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "journal-title": "Annu. Rev. Pharmacol. Toxicol.",
      "key": "10.1016/j.ajhg.2023.09.001_bib5",
      "volume": "55",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajmg.c.31391",
      "article-title": "PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics",
      "author": "Hoffman",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Am. J. Med. Genet. C Semin. Med. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib6",
      "volume": "166C",
      "year": "2014"
    },
    {
      "DOI": "10.1136/bmj.i2139",
      "article-title": "Medical error-the third leading cause of death in the US",
      "author": "Makary",
      "doi-asserted-by": "crossref",
      "first-page": "i2139",
      "journal-title": "BMJ",
      "key": "10.1016/j.ajhg.2023.09.001_bib7",
      "volume": "353",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S0140-6736(22)01841-4",
      "article-title": "A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study",
      "author": "Swen",
      "doi-asserted-by": "crossref",
      "first-page": "347",
      "journal-title": "Lancet",
      "key": "10.1016/j.ajhg.2023.09.001_bib8",
      "volume": "401",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41436-020-0788-3",
      "article-title": "The landscape of pharmacogenetic testing in a US managed care population",
      "author": "Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "1247",
      "journal-title": "Genet. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib9",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41436-021-01117-w",
      "article-title": "Expanding evidence leads to new pharmacogenomics payer coverage",
      "author": "Empey",
      "doi-asserted-by": "crossref",
      "first-page": "830",
      "journal-title": "Genet. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib10",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.japh.2019.10.003",
      "article-title": "Coverage of pharmacogenetic tests by private health insurance companies",
      "author": "Park",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "journal-title": "J. Am. Pharm. Assoc.",
      "key": "10.1016/j.ajhg.2023.09.001_bib11",
      "volume": "60",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cpt.2122",
      "article-title": "Pharmacogenetics at Scale: An Analysis of the UK Biobank",
      "author": "McInnes",
      "doi-asserted-by": "crossref",
      "first-page": "1528",
      "journal-title": "Clin. Pharmacol. Thera",
      "key": "10.1016/j.ajhg.2023.09.001_bib12",
      "volume": "109",
      "year": "2020"
    },
    {
      "DOI": "10.1038/clpt.2014.137",
      "article-title": "Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems",
      "author": "Rasmussen-Torvik",
      "doi-asserted-by": "crossref",
      "first-page": "482",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib13",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s12967-022-03745-5",
      "article-title": "Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population",
      "author": "Verma",
      "doi-asserted-by": "crossref",
      "first-page": "550",
      "journal-title": "J. Transl. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib14",
      "volume": "20",
      "year": "2022"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2019.5345",
      "article-title": "Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users",
      "author": "Chanfreau-Coffinier",
      "doi-asserted-by": "crossref",
      "journal-title": "JAMA Netw. Open",
      "key": "10.1016/j.ajhg.2023.09.001_bib15",
      "volume": "2",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00439-021-02260-9",
      "article-title": "Pharmacogenetics in developing countries and low resource environments",
      "author": "El Shamieh",
      "doi-asserted-by": "crossref",
      "first-page": "1159",
      "journal-title": "Hum. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib16",
      "volume": "141",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.pone.0274339",
      "article-title": "Pharmacogenetic allele variant frequencies: An analysis of the VA’s Million Veteran Program (MVP) as a representation of the diversity in US population",
      "author": "Markianos",
      "doi-asserted-by": "crossref",
      "journal-title": "PLoS One",
      "key": "10.1016/j.ajhg.2023.09.001_bib17",
      "volume": "18",
      "year": "2023"
    },
    {
      "DOI": "10.1002/cpt.1944",
      "article-title": "Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing",
      "author": "Zhou",
      "doi-asserted-by": "crossref",
      "first-page": "160",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib18",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-018-0579-z",
      "article-title": "The UK Biobank resource with deep phenotyping and genomic data",
      "author": "Bycroft",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2023.09.001_bib19",
      "volume": "562",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jclinepi.2015.09.016",
      "article-title": "Million Veteran Program: A mega-biobank to study genetic influences on health and disease",
      "author": "Gaziano",
      "doi-asserted-by": "crossref",
      "first-page": "214",
      "journal-title": "J. Clin. Epidemiol.",
      "key": "10.1016/j.ajhg.2023.09.001_bib20",
      "volume": "70",
      "year": "2016"
    },
    {
      "article-title": "H3Africa: current perspectives",
      "author": "Mulder",
      "first-page": "59",
      "journal-title": "Pharmgenomics. Pers. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib21",
      "volume": "11",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.je.2016.12.005",
      "article-title": "Overview of the BioBank Japan Project: Study design and profile",
      "author": "Nagai",
      "doi-asserted-by": "crossref",
      "first-page": "S2",
      "journal-title": "J. Epidemiol.",
      "key": "10.1016/j.ajhg.2023.09.001_bib22",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMsr1809937",
      "article-title": "The ‘All of Us’ Research Program",
      "author": "Denny",
      "doi-asserted-by": "crossref",
      "first-page": "668",
      "journal-title": "N. Engl. J. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib23",
      "volume": "381",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.2790",
      "article-title": "How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)",
      "author": "Li",
      "doi-asserted-by": "crossref",
      "first-page": "1036",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib24",
      "volume": "113",
      "year": "2023"
    },
    {
      "DOI": "10.1002/cpt.1568",
      "article-title": "Pharmacogenomics Clinical Annotation Tool (PharmCAT)",
      "author": "Sangkuhl",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib25",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cpt.928",
      "article-title": "PharmCAT: A Pharmacogenomics Clinical Annotation Tool",
      "author": "Klein",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib26",
      "volume": "104",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2016.87",
      "article-title": "Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)",
      "author": "Caudle",
      "doi-asserted-by": "crossref",
      "first-page": "215",
      "journal-title": "Genet. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib27",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41586-022-04965-x",
      "article-title": "The sequences of 150,119 genomes in the UK Biobank",
      "author": "Halldorsson",
      "doi-asserted-by": "crossref",
      "first-page": "732",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2023.09.001_bib28",
      "volume": "607",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-021-04103-z",
      "article-title": "Exome sequencing and analysis of 454,787 UK Biobank participants",
      "author": "Backman",
      "doi-asserted-by": "crossref",
      "first-page": "628",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2023.09.001_bib29",
      "volume": "599",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41588-021-00885-0",
      "article-title": "Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank",
      "author": "Szustakowski",
      "doi-asserted-by": "crossref",
      "first-page": "942",
      "journal-title": "Nat. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib30",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-020-2853-0",
      "article-title": "Exome sequencing and characterization of 49,960 individuals in the UK Biobank",
      "author": "Van Hout",
      "doi-asserted-by": "crossref",
      "first-page": "749",
      "journal-title": "Nature",
      "key": "10.1016/j.ajhg.2023.09.001_bib31",
      "volume": "586",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13742-015-0047-8",
      "article-title": "Second-generation PLINK: rising to the challenge of larger and richer datasets",
      "author": "Chang",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "journal-title": "GigaScience",
      "key": "10.1016/j.ajhg.2023.09.001_bib32",
      "volume": "4",
      "year": "2015"
    },
    {
      "DOI": "10.1093/gigascience/giab008",
      "article-title": "Twelve years of SAMtools and BCFtools",
      "author": "Danecek",
      "doi-asserted-by": "crossref",
      "first-page": "giab008",
      "journal-title": "GigaScience",
      "key": "10.1016/j.ajhg.2023.09.001_bib33",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.jmoldx.2019.06.007",
      "article-title": "Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project",
      "author": "Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "1034",
      "journal-title": "J. Mol. Diagn.",
      "key": "10.1016/j.ajhg.2023.09.001_bib34",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jmoldx.2021.12.011",
      "article-title": "CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project",
      "author": "Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "journal-title": "J. Mol. Diagn.",
      "key": "10.1016/j.ajhg.2023.09.001_bib35",
      "volume": "24",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.08.005",
      "article-title": "Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project",
      "author": "Pratt",
      "doi-asserted-by": "crossref",
      "first-page": "109",
      "journal-title": "J. Mol. Diagn.",
      "key": "10.1016/j.ajhg.2023.09.001_bib36",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jmoldx.2021.04.012",
      "article-title": "Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project",
      "author": "Pratt",
      "doi-asserted-by": "crossref",
      "first-page": "952",
      "journal-title": "J. Mol. Diagn.",
      "key": "10.1016/j.ajhg.2023.09.001_bib37",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.cell.2022.08.004",
      "article-title": "High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios",
      "author": "Byrska-Bishop",
      "doi-asserted-by": "crossref",
      "first-page": "3426",
      "journal-title": "Cell",
      "key": "10.1016/j.ajhg.2023.09.001_bib38",
      "volume": "185",
      "year": "2022"
    },
    {
      "DOI": "10.1093/nar/gkz836",
      "article-title": "The International Genome Sample Resource (IGSR) collection of open human genomic variation resources",
      "author": "Fairley",
      "doi-asserted-by": "crossref",
      "first-page": "D941",
      "journal-title": "Nucleic Acids Res.",
      "key": "10.1016/j.ajhg.2023.09.001_bib39",
      "volume": "48",
      "year": "2020"
    },
    {
      "DOI": "10.1093/bioinformatics/btv112",
      "article-title": "Unified representation of genetic variants",
      "author": "Tan",
      "doi-asserted-by": "crossref",
      "first-page": "2202",
      "journal-title": "Bioinformatics",
      "key": "10.1016/j.ajhg.2023.09.001_bib40",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.1322",
      "article-title": "Standardized biogeographic grouping system for annotating populations in pharmacogenetic research",
      "author": "Huddart",
      "doi-asserted-by": "crossref",
      "first-page": "1256",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib41",
      "volume": "105",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrg3849",
      "article-title": "Cystic fibrosis genetics: from molecular understanding to clinical application",
      "author": "Cutting",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Nat. Rev. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib42",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2015.52",
      "article-title": "Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk",
      "author": "Lim",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "journal-title": "Genet. Med.",
      "key": "10.1016/j.ajhg.2023.09.001_bib43",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1038/clpt.2014.54",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype",
      "author": "Clancy",
      "doi-asserted-by": "crossref",
      "first-page": "592",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib44",
      "volume": "95",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.911",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update",
      "author": "Amstutz",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib45",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.21105/joss.01686",
      "article-title": "Welcome to the Tidyverse",
      "author": "Wickham",
      "doi-asserted-by": "crossref",
      "first-page": "1686",
      "journal-title": "J. Open Source Softw.",
      "key": "10.1016/j.ajhg.2023.09.001_bib46",
      "volume": "4",
      "year": "2019"
    },
    {
      "DOI": "10.1038/clpt.2014.97",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype",
      "author": "Relling",
      "doi-asserted-by": "crossref",
      "first-page": "169",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib47",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.2735",
      "article-title": "Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype",
      "author": "Gammal",
      "doi-asserted-by": "crossref",
      "first-page": "973",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib48",
      "volume": "113",
      "year": "2023"
    },
    {
      "DOI": "10.1002/cpt.1830",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs",
      "author": "Theken",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib49",
      "volume": "108",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cpt.2008",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update",
      "author": "Karnes",
      "doi-asserted-by": "crossref",
      "first-page": "302",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib50",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.668",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update",
      "author": "Johnson",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib51",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fphar.2022.930470",
      "article-title": "Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population",
      "author": "Hishinuma",
      "doi-asserted-by": "crossref",
      "journal-title": "Front. Pharmacol.",
      "key": "10.1016/j.ajhg.2023.09.001_bib52",
      "volume": "13",
      "year": "2022"
    },
    {
      "DOI": "10.1002/cpt.1973",
      "article-title": "PharmVar GeneFocus: CYP2C19",
      "author": "Botton",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib53",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.147",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors",
      "author": "Hicks",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib54",
      "volume": "98",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.2015",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing",
      "author": "Lima",
      "doi-asserted-by": "crossref",
      "first-page": "1417",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib55",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.583",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy",
      "author": "Moriyama",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib56",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1124/dmd.115.064428",
      "article-title": "The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19∗35 and CYP2C19∗2 Alleles",
      "author": "Chaudhry",
      "doi-asserted-by": "crossref",
      "first-page": "1226",
      "journal-title": "Drug Metab. Dispos.",
      "key": "10.1016/j.ajhg.2023.09.001_bib57",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.910",
      "article-title": "The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database",
      "author": "Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "399",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib58",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.2321",
      "article-title": "Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation",
      "author": "Gaedigk",
      "doi-asserted-by": "crossref",
      "first-page": "542",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib59",
      "volume": "110",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.cell.2019.04.032",
      "article-title": "The Missing Diversity in Human Genetic Studies",
      "author": "Sirugo",
      "doi-asserted-by": "crossref",
      "first-page": "1080",
      "journal-title": "Cell",
      "key": "10.1016/j.ajhg.2023.09.001_bib60",
      "volume": "177",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cell.2023.01.042",
      "article-title": "Whole-genome sequencing reveals a complex African population demographic history and signatures of local adaptation",
      "author": "Fan",
      "doi-asserted-by": "crossref",
      "first-page": "923",
      "journal-title": "Cell",
      "key": "10.1016/j.ajhg.2023.09.001_bib61",
      "volume": "186",
      "year": "2023"
    },
    {
      "DOI": "10.1002/cpt.1477",
      "article-title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy",
      "author": "Desta",
      "doi-asserted-by": "crossref",
      "first-page": "726",
      "journal-title": "Clin. Pharmacol. Ther.",
      "key": "10.1016/j.ajhg.2023.09.001_bib62",
      "volume": "106",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pgs.11.160",
      "article-title": "Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment",
      "author": "Li",
      "doi-asserted-by": "crossref",
      "first-page": "555",
      "journal-title": "Pharmacogenomics",
      "key": "10.1016/j.ajhg.2023.09.001_bib63",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs.16.7",
      "article-title": "CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population",
      "author": "Mukonzo",
      "doi-asserted-by": "crossref",
      "first-page": "603",
      "journal-title": "Pharmacogenomics",
      "key": "10.1016/j.ajhg.2023.09.001_bib64",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1469-1809.2010.00638.x",
      "article-title": "Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations",
      "author": "Horsfall",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "journal-title": "Ann. Hum. Genet.",
      "key": "10.1016/j.ajhg.2023.09.001_bib65",
      "volume": "75",
      "year": "2011"
    }
  ],
  "reference-count": 65,
  "references-count": 65,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0002929723003142"
    }
  },
  "score": 0,
  "short-container-title": [
    "The American Journal of Human Genetics"
  ],
  "source": "Crossref",
  "title": [
    "Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
  "volume": "110"
}